Splanchnic Vein Thrombosis in Myeloproliferative Neoplasms: Risk Factors for Recurrences in a Cohort of 181 Patients

Despite anticoagulation treatment, the recurrence rate after SVT in myeloproliferative neoplasms is high and suggests the exploration of new avenues of secondary prophylaxis with new antithrombotic drugs and JAK-2 inhibitors.

 Blood Cancer J

click me